Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/131435 |
Resumo: | Patients in intensive care unit are prescribed large numbers of drugs, highlighting the need to study potential Drug-Drug Interactions in this environment. The aim of this study was to delineate the prevalence and risk of potential drug-drug interactions between medications administered to patients in an ICU. This cross-sectional observational study was conducted during 12 months, in an adult ICU of a teaching hospital. Inclusion criteria were: prescriptions with 2 or more drugs of patients admitted to the ICU for >; 24 hours and age of ≥18 years. Potential Drug-Drug Interactions were quantified and classified through MicromedexTM database. The 369 prescriptions included in this study had 205 different drugs, with an average of 13.04 ± 4.26 (mean ± standard deviation) drugs per prescription. Potential Drug-Drug Interactions were identified in 89% of these, with an average of 5.00 ± 5.06 interactions per prescription. Of the 405 different pairs of potentially interacting drugs identified, moderate and major interactions were present in 74% and 67% of prescriptions, respectively. The most prevalent interaction was between dipyrone and enoxaparin (35.8%), though its clinical occurrence was not observed in this study. The number of potential Drug-Drug Interactions showed significant positive correlations with the length of stay in the intensive care unit, and with the number of prescribed drugs. Acknowledging the high potential for Drug-Drug Interactions in the ICU represents an important step toward improving patient safety and best therapy results. |
id |
USP-31_ed9339f8e7adfc15fabe0c22fc83e33a |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/131435 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospitalPotential drug-drug interactionsIntensive care unitPatient safetyUniversity hospitals.Patients in intensive care unit are prescribed large numbers of drugs, highlighting the need to study potential Drug-Drug Interactions in this environment. The aim of this study was to delineate the prevalence and risk of potential drug-drug interactions between medications administered to patients in an ICU. This cross-sectional observational study was conducted during 12 months, in an adult ICU of a teaching hospital. Inclusion criteria were: prescriptions with 2 or more drugs of patients admitted to the ICU for >; 24 hours and age of ≥18 years. Potential Drug-Drug Interactions were quantified and classified through MicromedexTM database. The 369 prescriptions included in this study had 205 different drugs, with an average of 13.04 ± 4.26 (mean ± standard deviation) drugs per prescription. Potential Drug-Drug Interactions were identified in 89% of these, with an average of 5.00 ± 5.06 interactions per prescription. Of the 405 different pairs of potentially interacting drugs identified, moderate and major interactions were present in 74% and 67% of prescriptions, respectively. The most prevalent interaction was between dipyrone and enoxaparin (35.8%), though its clinical occurrence was not observed in this study. The number of potential Drug-Drug Interactions showed significant positive correlations with the length of stay in the intensive care unit, and with the number of prescribed drugs. Acknowledging the high potential for Drug-Drug Interactions in the ICU represents an important step toward improving patient safety and best therapy results.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2017-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/13143510.1590/s2175-97902017000116109Brazilian Journal of Pharmaceutical Sciences; Vol. 53 Núm. 1 (2017); e16109-Brazilian Journal of Pharmaceutical Sciences; v. 53 n. 1 (2017); e16109-Brazilian Journal of Pharmaceutical Sciences; Vol. 53 No. 1 (2017); e16109-2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/131435/127815Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessRodrigues, Aline TeotonioStahlschmidt, RebecaGranja, SilviaPilger, DiogoFalcão, Antonio Luis EirasMazzola, Priscila Gava2017-04-20T20:28:50Zoai:revistas.usp.br:article/131435Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2017-04-20T20:28:50Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital |
title |
Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital |
spellingShingle |
Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital Rodrigues, Aline Teotonio Potential drug-drug interactions Intensive care unit Patient safety University hospitals. |
title_short |
Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital |
title_full |
Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital |
title_fullStr |
Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital |
title_full_unstemmed |
Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital |
title_sort |
Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital |
author |
Rodrigues, Aline Teotonio |
author_facet |
Rodrigues, Aline Teotonio Stahlschmidt, Rebeca Granja, Silvia Pilger, Diogo Falcão, Antonio Luis Eiras Mazzola, Priscila Gava |
author_role |
author |
author2 |
Stahlschmidt, Rebeca Granja, Silvia Pilger, Diogo Falcão, Antonio Luis Eiras Mazzola, Priscila Gava |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Rodrigues, Aline Teotonio Stahlschmidt, Rebeca Granja, Silvia Pilger, Diogo Falcão, Antonio Luis Eiras Mazzola, Priscila Gava |
dc.subject.por.fl_str_mv |
Potential drug-drug interactions Intensive care unit Patient safety University hospitals. |
topic |
Potential drug-drug interactions Intensive care unit Patient safety University hospitals. |
description |
Patients in intensive care unit are prescribed large numbers of drugs, highlighting the need to study potential Drug-Drug Interactions in this environment. The aim of this study was to delineate the prevalence and risk of potential drug-drug interactions between medications administered to patients in an ICU. This cross-sectional observational study was conducted during 12 months, in an adult ICU of a teaching hospital. Inclusion criteria were: prescriptions with 2 or more drugs of patients admitted to the ICU for >; 24 hours and age of ≥18 years. Potential Drug-Drug Interactions were quantified and classified through MicromedexTM database. The 369 prescriptions included in this study had 205 different drugs, with an average of 13.04 ± 4.26 (mean ± standard deviation) drugs per prescription. Potential Drug-Drug Interactions were identified in 89% of these, with an average of 5.00 ± 5.06 interactions per prescription. Of the 405 different pairs of potentially interacting drugs identified, moderate and major interactions were present in 74% and 67% of prescriptions, respectively. The most prevalent interaction was between dipyrone and enoxaparin (35.8%), though its clinical occurrence was not observed in this study. The number of potential Drug-Drug Interactions showed significant positive correlations with the length of stay in the intensive care unit, and with the number of prescribed drugs. Acknowledging the high potential for Drug-Drug Interactions in the ICU represents an important step toward improving patient safety and best therapy results. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/131435 10.1590/s2175-97902017000116109 |
url |
https://www.revistas.usp.br/bjps/article/view/131435 |
identifier_str_mv |
10.1590/s2175-97902017000116109 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/131435/127815 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso) |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 53 Núm. 1 (2017); e16109- Brazilian Journal of Pharmaceutical Sciences; v. 53 n. 1 (2017); e16109- Brazilian Journal of Pharmaceutical Sciences; Vol. 53 No. 1 (2017); e16109- 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222913210613760 |